UBS AM
SGYP

UBS AM’s Synergy Pharmaceuticals, Inc Common Stock SGYP Stock Holding History

UBS AM’s Portfolio SGYP Stock Details SGYP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-80,394
Closed -$137K – 2854
2018
Q3 		$137K Hold
80,394
– – ﹤0.01% 2502
2018
Q2 		$140K Hold
80,394
– – ﹤0.01% 2534
2018
Q1 		$147K Hold
80,394
– – ﹤0.01% 2429
2017
Q4 		$179K Hold
80,394
– – ﹤0.01% 2340
2017
Q3 		$233K Buy
80,394
+1,615
+2% +$5.51K ﹤0.01% 2179
2017
Q2 		$351K Buy
78,779
+143
+0.2% +$590 ﹤0.01% 1975
2017
Q1 		$366K Buy
78,636
+25,300
+47% +$147K ﹤0.01% 1949
2016
Q4 		$325K Sell
53,336
-5,500
-9% -$28.7K ﹤0.01% 1918
2016
Q3 		$325K Buy
58,836
+14,436
+33% +$67.6K ﹤0.01% 2224
2016
Q2 		$169K Hold
44,400
– – ﹤0.01% 2494
2016
Q1 		$123K Sell
44,400
-5,300
-11% -$19.2K ﹤0.01% 2542
2015
Q4 		$282K Sell
49,700
-585,200
-92% -$3.57M ﹤0.01% 2369
2015
Q3 		$3.37M Sell
634,900
-3,800
-0.6% -$29.4K ﹤0.01% 1195
2015
Q2 		$5.3M Buy
638,700
+3,300
+0.5% +$16K 0.01% 1039
2015
Q1 		$2.94M Buy
635,400
+2,600
+0.4% +$8.46K ﹤0.01% 1213
2014
Q4 		$1.93M Buy
632,800
+13,000
+2% +$38.4K ﹤0.01% 1339
2014
Q3 		$1.73M Hold
619,800
– – ﹤0.01% 1356
2014
Q2 		$2.52M Hold
619,800
– – ﹤0.01% 1242
2014
Q1 		$3.29M Sell
619,800
-8,677
-1% -$48.6K ﹤0.01% 1151
2013
Q4 		$3.49M Sell
628,477
-4,969
-0.8% -$21.4K ﹤0.01% 1105
2013
Q3 		$2.85M Buy
+633,446
New +$2.84M ﹤0.01% 1128

Other funds holding SGYP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
OCM
Opti Capital Management New York $1.64B AUM 0% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return

UBS AM's SGYP Position: Q4 2018 in Review

UBS AM sold out of Synergy Pharmaceuticals, Inc Common Stock (SGYP) in Q4 2018, closing a stake of 80,394 shares — an estimated $137K sold.

UBS AM first reported a position in SGYP in Q3 2013 and held it in 21 quarters. The position peaked at $5.3M in Q2 2015. 89 funds tracked by Wall St. Rank hold SGYP as of Q4 2018.

  • UBS AM reported no remaining Synergy Pharmaceuticals, Inc Common Stock position as of Q4 2018 after selling out during the quarter.
  • UBS AM sold 80,394 Synergy Pharmaceuticals, Inc Common Stock shares in Q4 2018, an estimated $137K.
  • UBS AM first reported a position in Synergy Pharmaceuticals, Inc Common Stock in Q3 2013 and held it in 21 quarters.
  • UBS AM's Synergy Pharmaceuticals, Inc Common Stock position peaked at $5.3M in Q2 2015.
  • 89 funds tracked by Wall St. Rank held Synergy Pharmaceuticals, Inc Common Stock as of Q4 2018.

Based on UBS AM's 13F filing for Q4 2018, filed 13 Feb 2019.